Information about Destock Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0788.250.902

VAT liability
Yes
Established
05-07-2022
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Destock Pharma

2025 2024
Profit/Loss -752 -15 % -655
Equity -1,396 -117 % -644
Gross margin -752 -17 % -642

Publications from Destock Pharma

Date Publication
09-10-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Denomination - Registered Office - Goal - Resignations, Appointments (FR)
16-06-2023 Resignations, Appointments (FR)
25-04-2023 Registered Office (FR)
16-08-2022 Resignations, Appointments (FR)
07-07-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Destock Pharma?
The VAT number of Destock Pharma is BE 0788.250.902.
Wat is the PEPPOL ID of Destock Pharma?
The PEPPOL ID of Destock Pharma is 0208:0788250902. Log in or start a free trial to see the full overview.
When was Destock Pharma founded?
Destock Pharma was founded on 05-07-2022.
What is the address of Destock Pharma?
The current registered office of Destock Pharma is located at Route de Gembloux Mehaigne 135/B, 5310 Eghezée.
When was the last time Destock Pharma filed their annual financial statements?
The most recent financial statements of Destock Pharma were filed on 17-02-2026.
How many employees does Destock Pharma have?
There are currently no employees working at Destock Pharma or no workforce information is available.
What is the annual turnover of Destock Pharma?
At the time of its most recent financial statements, Destock Pharma did not publish any turnover figures. Destock Pharma reported a gross margin of -€751.98.